Colonoscopy trial - Accellacare
27/1/2026
Published on
28/1/2026
LivingCare was commissioned to design and deliver a comprehensive pre-endoscopy COVID-19 swabbing programme to enable the safe continuation of diagnostic procedures during the COVID-19 pandemic.
The service supported patients attending for gastroscopy, colonoscopy, flexible sigmoidoscopy and cystoscopy across LivingCare clinics, independent sector providers and NHS hospitals.
The programme ensured that all patients were confirmed COVID-negative prior to procedures, meeting infection prevention and control requirements while maintaining essential diagnostic capacity.
LivingCare managed the complete end-to-end swabbing pathway, including patient booking and communication, clinical swabbing, courier logistics, laboratory liaison and timely result reporting.
We operated across multiple delivery sites to ensure accessibility and worked closely with endoscopy units, laboratory teams and infection control leads to ensure real-time coordination. Robust clinical governance, data protection and quality assurance frameworks were embedded throughout delivery.
LivingCare also implemented digital systems to enable automated alerts and real-time result visibility for endoscopy teams, reducing manual processes and supporting proactive management of delays or anomalies.
The programme was delivered successfully throughout a period of rapidly changing national guidance. It enabled thousands of patients, including those on urgent cancer referral pathways, to proceed safely with diagnostic procedures during the pandemic.
The service achieved full compliance with testing timelines and maintained essential diagnostic services at a critical time for the NHS.
West Yorkshire Integrated Care Board (ICB)
Pre-procedure COVID-19 testing to support endoscopic diagnostic research and clinical pathways
Thousands of patients supported (including Two-Week Wait referrals)
2020 - 2022
Leeds & Wakefield